When NotPetya ransomware devastated Merck & Co. in 2017, the pharmaceutical giant faced £1.4 billion in losses and widespread operational chaos. Their experience serves as a sobering reminder: for biotech and pharmaceutical companies, technology failures don’t just mean downtime.
IT crises can threaten patient outcomes, compromise years of research, and trigger financial losses that, for many, will take years to recover from. Despite these stakes, the sector remains cautiously traditional with its IT infrastructure. Many still rely on legacy systems that grow more vulnerable by the day.
It’s not like there isn’t an alternative; secure cloud services offer a path forward that strengthens (rather than compromises) the industry’s commitment to regulatory compliance, data integrity, and operational resilience. But uptake is slower than you might expect – which is why today, we’re going to try and change that.
Cloud Uptake in the Biotech and Pharmaceutical Industry
Back in 2023, 74% of UK organisations surveyed by PwC said they were planning on increasing their cloud budget in the following year. The 16% of ‘all-in’ respondents (those who had scaled cloud adoption throughout their business) were more likely to be faster to market, access cost savings, and see increased innovation. Clearly, there’s a huge amount of value to be found in cloud services – yet some organisations remain reluctant to invest.
Nowhere is this more pronounced than in the biotech and pharmaceutical sphere. Compared to other industries, these sectors are significantly late adopters:
- In 2021, spending on cloud services for biotech businesses totalled $17.2 billion. (For context, the global spend on the cloud in the same year was $332.3 billion.)
- By 2024, industry spending had only increased to $18.3 billion. With a growing number of demands prompting the use of remotely hosted, widely accessible tools and databases, you’d think these businesses would be rushing to incorporate pharma cloud services. Instead, they’re standing their ground.
This cautious approach is understandable given the highly regulated nature of these industries and the sensitivity of the data they handle. However, it’s also – ironically – increasing risk in the long term.
Protecting Regulated Data Through Secure Cloud Services
Data security remains one of the most critical concerns for pharmaceutical and biotech organisations. Patient information, clinical trial data, intellectual property, and proprietary research all require reliable protection against unauthorised access, corruption, or loss.
Today’s cloud security solutions for pharma provide multiple layers of sophisticated defences. They often exceed what most organisations can implement in-house:
- Advanced Encryption Capabilities: State-of-the-art encryption for data both in transit and at rest. This ensures that regulated information remains protected regardless of where it’s stored or how it’s being accessed.
Unlike traditional systems, where manual encryption may be applied inconsistently, cloud platforms implement it systematically across all data.
- Comprehensive Access Controls: Sophisticated identity and access management features, including multi-factor authentication, role-based access controls, just-in-time privileged access, and continuous monitoring and anomaly detection.
These controls ensure only authorised personnel can access specific data sets, with all interactions thoroughly logged for audit and compliance purposes.
- Automated Security Updates: One significant advantage of cloud services for biotech businesses is the automatic implementation of security patches and updates.
Traditionally, manual updates end up delayed due to resource constraints or concerns about system disruption. In contrast, cloud providers can deploy patches rapidly across their infrastructure, ensuring vulnerabilities are always addressed promptly.
- Real-time Threat Detection: Cloud security monitoring operates 24/7. Advanced analytics and machine learning identify potential security threats before they can impact your operations.
For pharmaceutical organisations dealing with valuable intellectual property, this constant vigilance provides peace of mind that traditional security approaches struggle to match.
But how do you make sure you’re getting the most from these security capabilities?
Best Practices for Data Protection
To maximise the benefits of secure cloud services, you should:
- Implement a comprehensive data classification system
- Establish clear policies for data handling in cloud environments
- Conduct regular security assessments of cloud configurations
- Train staff on cloud security protocols and practices
- Maintain detailed logs and audit trails for all cloud activities
By following these best practices, you can ensure your transition to the cloud doesn’t compromise your data security posture.
Maintaining Compliance in a Cloud-Based Environment
Regulatory compliance is foundational to your ability to operate. The good news is that pharma cloud services can actually facilitate compliance, rather than complicating it.
- Addressing Pharmaceutical-Specific Regulations: Cloud providers must be compliant with GDPR and HIPAA – but pharma and biotech businesses have regulatory requirements that extend beyond this. This includes EU Annex 11 and 21 CFR Part 11, which we’ve explored in previous blogs on ensuring data integrity.
Leading cloud security solutions for pharma are designed with these requirements in mind. They incorporate features that support validation, audit trails, electronic signatures, and data integrity.
- Automated Compliance Monitoring: Modern cloud platforms offer automated compliance monitoring tools that continuously assess your environment against regulatory requirements.
These tools can identify potential compliance gaps and alert administrators to configuration changes that may affect compliance.
- Enhanced Documentation and Record-Keeping: Secure cloud services excel at maintaining the detailed documentation required for pharmaceutical compliance.
Cloud-based systems automatically generate and preserve records of all data manipulations, system changes, and user interactions – creating an immutable audit trail that satisfies regulatory requirements.
This approach reduces the manual effort traditionally associated with compliance management, allowing you to maintain regulatory adherence without diverting resources from your core business activities.
Using Cloud Solutions to Ensure Biotech Business Continuity
Ensuring business continuity is particularly critical in an industry where disruptions can have serious implications for patient care and safety. Cloud services provide robust solutions for maintaining operations through a variety of challenges:
- Improved Collaboration and Remote Access: Cloud services enable secure remote access to critical applications and data, making real-time collaboration on documents and research findings across locations (and even continents) possible.
This flexibility not only supports biotech business continuity during disruptive events but also enhances day-to-day productivity and collaboration. Your staff benefit from seamless sharing of large datasets across multiple locations and mobile access to key systems when working in the field.
- Scalable Computing Resources: Decentralised clinical trials (a growing trend in the pharma and biotech industry) often involve processing massive datasets – a task that can strain traditional IT infrastructure.
Cloud services provide on-demand access to virtually unlimited computing power. This lets you conduct things like rapid analysis of clinical trial data, complex molecular modelling and simulation, AI-powered drug discovery,and large-scale genomic sequencing faster than ever, without sacrificing accuracy or data integrity. You can make your next breakthrough without needing to bring operations to a halt for installations.
- Enhanced Disaster Recovery Capabilities: Traditional disaster recovery approaches often involve maintaining duplicate physical infrastructure at secondary locations. It’s a costly and complex undertaking.
Cloud services for biotech businesses change the story by providing geographic redundancy across multiple data centres, automatic failover capabilities, and point-in-time recovery options. Aside from reduced recovery time objectives, the outcome is minimal data loss in the event of an emergency, thanks to continuous backups.
Best Practices for Maintaining Business Continuity in the Cloud
You’ll benefit the most from the continuity potential of cloud services designed for pharma when you:
- Develop and regularly test comprehensive business continuity plans
- Implement multi-region deployments for critical applications
- Establish clear recovery time objectives (RTOs) and recovery point objectives (RPOs)
- Conduct regular failover testing to verify continuity capabilities
- Ensure staff are trained on continuity procedures and alternative working arrangements
With these practices in place, your pharmaceutical or biotech organisation can maintain essential operations through a wide range of potential disruptions.
The Key Benefits of Cloud Services for Biotech and Pharma Businesses
The advantages of adopting secure cloud services extend beyond security, compliance, and continuity. Here are five more key business benefits for pharmaceutical and biotech organisations:
Customised Solutions for Pharmaceutical Workflows
Cloud services for biotech businesses aren’t one-size-fits-all. There’s a vast array of solutions to choose from, giving you the power to create a technology setup that supports your exact operational needs.
Industry-specific cloud solutions even incorporate GxP principles at their core, rather than treating compliance as an afterthought. This purpose-built approach means:
- Less complexity in determining if a solution meets regulatory requirements
- Workflows designed specifically for pharmaceutical processes
- Integration capabilities with laboratory instruments and systems
- Industry-specific analytics and reporting functions
By selecting a personalised mix of cloud solutions designed for the pharmaceutical sector, you can accelerate adoption and maximise returns on your IT investments.
Straightforward Scaling
Whether it’s due to new product approvals, research breakthroughs, or market expansions, growth in pharmaceutical and biotech organisations often comes in surges. Secure cloud services accommodate this pattern better than traditional IT infrastructure through:
- Subscription-based models that allow for easy addition of users or capacity
- Rapid provisioning of new environments for projects or clinical trials
- Ability to expand computational resources during peak analysis periods
- Global deployment options to support international expansion
This flexibility eliminates the delays and capital expenses traditionally associated with scaling IT infrastructure, allowing your organisation to respond quickly to new opportunities. If you’re expanding operations and find you need to add more team members, endpoints, or storage to your plan, you can do so in just a few clicks.
Lower Costs and Predictable Budgeting
Compared to traditional software and hardware, cloud security solutions for pharma are predictably priced (and kinder to your budget). You don’t have to factor in hardware failures or emergency repair costs. Since they’ll be configured to comply with GxP requirements, you shouldn’t be left facing non-compliance fines. Similarly, their security features mean you won’t be recouping losses caused by successful cyber-attacks or data breaches.
All the while, you remain firmly in control of how much you’re spending. If you no longer need coverage for so many users or decide that a certain application isn’t demonstrating a good enough ROI, you can remove them from your plan with minimal fuss.
Businesses that use cloud solutions are able to:
- Eliminate hardware refresh cycles and associated capital expenses
- Reduce physical infrastructure and data centre costs
- Decrease the need for specialised IT staff to maintain complex systems
- Provide pay-for-use pricing that aligns costs with actual consumption
- Avoid over-provisioning for peak demand scenarios
So it’s not surprising that they save, on average, 20% as a result of their cloud approach.
Reduced Infrastructure Complexity
Traditional pharmaceutical IT environments often evolve into complex patchworks of systems and technologies. Rapidly evolving regulations necessitate constant change, and growth often leads to an IT setup comprising components that function perfectly alone but don’t work well together.
As a result, your employees’ jobs become more challenging, data integrity is threatened, and security risk increases. It’s also, frankly, a nightmare to manage.
Pharma cloud services reduce this complexity through:
- Standardised, consistent infrastructure
- Centralised management and monitoring
- Automated maintenance and updates
- Integrated security and compliance controls
- Unified data storage and access policies
As well as reducing your operational overhead, this simplification also minimises the risk of configuration errors and compliance gaps that can arise in more complex environments.
Enhanced Competitive Position
Finally, secure cloud services can also significantly strengthen your organisation’s competitive position. They enable things like:
- Accelerated research and development cycles
- Faster clinical trial setup and data analysis
- Improved collaboration with research partners and contract organisations
- A stronger ability to use revolutionary tools like AI and machine learning
All in all, this equips you with agility – a better ability to respond to market opportunities and regulatory changes quickly and effectively.
How Could Cloud Services Fit into Your Pharma or Biotech Business?
Find out through an expert audit.
Specifically crafted to tackle the unique challenges of the pharma industry, our bespoke audits help identify gaps, mitigate risks, and ensure compliance. You’ll receive a clear, actionable plan to address identified risks, ensuring your technology environment supports safe and effective product development and distribution.
Overcoming Common Challenges in Adopting Cloud Solutions for Pharmaceutical Companies
Despite the compelling benefits, pharmaceutical and biotech organisations hesitate to transition to cloud services for biotech businesses. Because of the pharmaceutical industry’s tendency to rely on technology that’s proven its value and reliability over the long term, businesses are often left trapped within an ecosystem that becomes increasingly outdated and more unsupported every year.
But these systems work well enough (or so the C-suite believes). Combined with concerns about moving to cloud-based alternatives, this prevents them from taking action.
The cycle continues, and the vulnerabilities mount – until you decide to make a change.
Cultural Resistance
Perhaps the most significant challenge is cultural resistance to change, particularly in an industry that values proven, stable processes. Overcoming this resistance requires:
- Clear communication of the specific benefits and risk mitigations of cloud adoption
- Education about modern cloud security capabilities and compliance features
- Involvement of quality and compliance teams throughout the planning process
- Phased implementation approaches that build confidence and demonstrate success
By addressing cultural concerns head-on and demonstrating the value of secure cloud services through pilot projects, your organisation can build the internal support necessary for successful cloud adoption.
Data Migration Complexity
Moving regulated data to cloud environments requires meticulous planning to ensure data integrity, security, and availability throughout the process. Successful data migration strategies include:
- Comprehensive data classification and risk assessment before migration
- Phased migration approaches that prioritise less critical data
- Detailed validation of data integrity before, during, and after migration
- Maintenance of parallel systems during transition periods to ensure biotech business continuity
Cloud adoption does present its challenges, but a risk-based approach helps to ensure the integrity and compliance of these modern solutions in pharmaceutical spaces. With proper planning and execution, even the most regulated pharmaceutical data can be safely migrated to cloud environments.
Validation Concerns
System validation is a critical requirement in pharmaceutical environments, and concerns about evaluating cloud-based systems often slow adoption.
ITforPharma can ensure your solutions are compliant, have suitable controls enabled, and have been through the necessary tests to reduce the odds of failure.
Our Cloud Solutions include:
- Microsoft 365 Implementation and Management: Secure, GxP-compliant Microsoft 365 deployment with comprehensive validation documentation, streamlined collaboration tools, and ongoing support (including user training to maximise productivity).
- Azure Cloud Services: Custom-tailored, cost-efficient Azure infrastructure solutions with secure identity management and robust backup systems. Designed to ensure business continuity while meeting pharmaceutical compliance requirements.
We’ll help your organisation maintain compliance while fully embracing the agility of cloud services.
Our Compliance-First Approach to Secure Cloud Services
We know that for businesses like yours, compliance can’t be an afterthought. It has to be the foundation of any technology strategy. That’s why we take a compliance-first approach to cloud security solutions for pharma – it ensures that regulatory requirements are met from the outset, rather than being addressed retroactively.
We oversee:
- Change control for regulated data
- Streamlined incident management
- Strict adherence to GxP standards
- Vendor management to ensure all your cloud services meet the same rigorous standards
We’ve also got plenty of free resources available to educate you on keeping your cloud systems secure.
Cloud Service FAQs for Pharma and Biotech Businesses
As you consider implementing cloud services for biotech businesses, you likely have questions about their application, benefits, and security implications. Read on for answers to the most common questions we receive from pharmaceutical and biotech organisations:
- How is cloud computing helpful in pharma and biotech?
Pharma cloud services provide industry-specific benefits, including:
- Enhanced data security through advanced encryption, access controls, and threat monitoring
- Streamlined regulatory compliance with automated documentation and audit trails
- Improved collaboration across research teams, manufacturing sites, and external partners
- Scalable computing resources for complex research and data analysis
- Reduced IT infrastructure costs and maintenance burdens
- Greater resilience and biotech business continuity through robust disaster recovery capabilities
- Are cloud solutions enough to keep clinical data secure?
While cloud security solutions for pharma provide impressive protection, advanced cyber security still requires a holistic approach.
Cloud solutions should be part of a broader security strategy that includes well-defined data governance policies and procedures, regular security awareness training for all staff, comprehensive vendor security assessments, ongoing monitoring and testing of security controls, incident response planning and regular drills, and regular compliance and security audits.
When implemented as part of this holistic approach, cloud solutions can actually enhance the security of clinical data compared to traditional on-premises environments.
- How many pharma businesses use secure cloud services?
Approximately 83% of pharmaceutical businesses now use some form of cloud-based technology, though the depth of implementation varies significantly. This number is divided amongst those who have:
- Adopted cloud solutions for non-GxP applications (those that aren’t subject to 21 CFR Part 11, EU Annex 11, and ICH guidelines) only
- Adopted cloud platforms for both GxP and non-GxP applications
- Implemented comprehensive cloud strategies across their operations
- How can cloud solutions support regulatory inspections and audits?
Pharma cloud services can significantly streamline regulatory inspections through centralised, searchable repositories of all compliance documentation. Many solutions enable automated generation of regulatory reports and metrics and provide complete, immutable audit trails of all data access and modifications.
You gain quick access to historical data and system configurations and assurance that standardised processes are being followed across multiple facilities and operations thanks to real-time monitoring dashboards.
As long as the cloud platform you choose is aligned with FDA, EU, and ICH standards, its capabilities can reduce the preparation time for regulatory inspections while improving the quality and completeness of the documentation you provide to inspectors.
- Who should we talk to about securing cloud services for our pharma or biotech business?
Us! Our cloud services are driven by a deep understanding of pharmaceutical and biotech regulatory requirements. We offer validated cloud environments designed specifically for GxP workloads. We can also provide assistance with compliance documentation and support, helping you maintain appropriate security certifications and controls across your company.
The right technology partner brings not just technical expertise but also a nuanced understanding of the unique needs of pharmaceutical and biotech organisations. We work hard to fit that bill – get in touch to see for yourself.
Is It Time for a Cloud-Enabled Future for Your Biotech or Pharma Business?
As we’ve explored throughout this article, secure cloud services offer pharmaceutical and biotech organisations powerful tools for protecting regulated data, maintaining regulatory compliance, and ensuring biotech business continuity. While the journey to cloud adoption presents challenges, the potential benefits make it one well worth undertaking.
By approaching cloud adoption strategically, with a focus on compliance and security from the outset, you can harness the transformative potential of cloud computing while meeting your regulatory obligations.
The result? Not just improved IT operations, but an all-around enhanced ability to fulfil your fundamental mission: developing and delivering life-changing therapies to patients safely and efficiently.
ITforPharma: Securing IT Regulatory Compliance and Regulated Data as Your Proven Technology Partner
As a specialised IT services partner to the pharmaceuticals sector, we’re an experienced and dedicated team serving businesses across the world.
We understand the web of regulations facing pharmaceutical companies and provide IT infrastructure support designed with compliance in mind. From fast, secure, and reliable technology to digital transformation solutions, we’re here to help you with all things IT.
Ready to explore how cloud services for biotech businesses could transform your operations? Contact our team to schedule a specialised audit and discover your path to secure, compliant cloud adoption.
